Big Pharma Should Pay Mannkind Big Bucks Just For Its Novel Inhaled Technoshpere Technology Alone !
Inhaled drug delivery in still virgin territory and there is absolutely no big drug pharmaceutical company or big drug delivery company that has a viable inhaled delivery device program or division in place today. The evolution of inhaled technology has taken a lot of turns over the years and there simply aren't any big pharma's working on it today. That being said developing effective new technology takes a lot of time and money, but when they get it right the rewards can be huge. I expect Alfred Mann's visionary outlook for Technoshere is the kind of technology that gets it right and it will lead to huge changes happening in the healthcare industry. Technosphere will reward the lucky company that gets it under their umbrella to leverage its full potential and introduce this game changing, paradigm changing technology to the world.
That's wrong. Pulmatrix is backed by Novartis and exclusively dedicated to a similar technology. Instead of that being a negative, it should be taken as a positive that validates the potential value of Technosphere.
Funny how the CEO of Novartis panned MNKD's inhaled insulin when Novartis is backing Pulmatrix.